$BIVI
BIOVIE INC. Stock $bivi

$bivi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000152013824000069 Filed on February 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.974M	$2.254M	$4.405M
YoY Change	-21.67%	-48.83%	118.46%
% of Gross Profit
Research & Development	$5.700M	$6.470M	$7.033M
YoY Change	-49.09%	-8.0%	53.17%
% of Gross Profit
Depreciation & Amortization	$57.34K	$54.69K	$57.35K
YoY Change	0.0%	-4.64%	0.0%
% of Gross Profit
Operating Expenses	$7.732M	$8.781M	$11.49M
YoY Change	-43.87%	-23.61%	72.46%
Operating Profit	-$7.732M	-$8.781M	-$11.49M
YoY Change	-43.87%	-23.61%	72.46%
Interest Expense	$628.7K	$820.6K	$1.053M
YoY Change	-41.93%	-22.1%	-15.77%
% of Operating Profit
Other Income/Expense, Net	-$335.8K	$380.0K	-$4.192M
YoY Change	-73.49%	-109.06%
Pretax Income	-$8.068M	-$8.401M	-$15.69M
YoY Change	-46.36%	-46.44%	189.73%
Income Tax
% Of Pretax Income
Net Earnings	-$8.068M	-$8.401M	-$15.69M
YoY Change	-46.36%	-46.44%	189.73%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.20	-$0.22	-$0.50
Diluted Earnings Per Share	-$0.20	-$0.22	-$0.50
COMMON SHARES
Basic Shares Outstanding	39.87M shares	37.74M shares	30.53M shares
Diluted Shares Outstanding	44.80M shares	38.17M shares	31.17M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.35M	$20.23M	$45.75M
YoY Change	-30.7%	-55.79%	50.53%
Cash & Equivalents	$30.35M	$20.23M	$45.75M
Short-Term Investments	$0.00
Other Short-Term Assets	$189.6K	$335.0K	$241.3K
YoY Change	-24.1%	38.83%	55.8%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$30.54M	$20.56M	$45.99M
YoY Change	-30.67%	-55.29%	50.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$422.2K	$60.42K	$100.0K
YoY Change	366.23%	-39.6%
Goodwill	$345.7K	$345.7K	$345.7K
YoY Change	0.0%	0.0%
Intangibles	$465.1K	$522.4K	$751.8K
YoY Change	-33.03%	-30.51%
Long-Term Investments
YoY Change
Other Assets			$4.562K
YoY Change
Total Long-Term Assets	$1.233M	$928.5K	$1.202M
YoY Change	8.6%	-22.76%	-9.4%
TOTAL ASSETS
Total Short-Term Assets	$30.54M	$20.56M	$45.99M
Total Long-Term Assets	$1.233M	$928.5K	$1.202M
Total Assets	$31.77M	$21.49M	$47.19M
YoY Change	-29.68%	-54.46%	48.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.410M	$3.608M	$3.245M
YoY Change	-8.87%	11.18%	95.14%
Accrued Expenses	$57.14K	$48.23K	$41.79K
YoY Change	31.93%	15.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.993M	$10.20M
YoY Change	25.06%
Total Short-Term Liabilities	$12.48M	$13.98M	$7.797M
YoY Change	-22.02%	79.32%	78.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$13.26M
YoY Change	-100.0%	-100.0%	19.35%
Other Long-Term Liabilities	$366.4K	$17.60K
YoY Change
Total Long-Term Liabilities	$366.4K	$17.60K	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.48M	$13.98M	$7.797M
Total Long-Term Liabilities	$366.4K	$17.60K	$0.00
Total Liabilities	$12.85M	$14.00M	$21.12M
YoY Change	-45.25%	-33.73%	33.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$329.3M	-$320.3M	-$277.1M
YoY Change	12.73%	15.62%
Common Stock	$348.2M	$327.8M	$303.1M
YoY Change	10.96%	8.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.00	$2.00
YoY Change	150.0%
Treasury Stock Shares
Shareholders Equity	$18.93M	$7.491M	$26.07M
YoY Change
Total Liabilities & Shareholders Equity	$31.77M	$21.49M	$47.19M
YoY Change	-29.68%	-54.46%	48.06%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$8.068M	-$8.401M	-$15.69M
YoY Change	-46.36%	-46.44%	189.73%
Depreciation, Depletion And Amortization	$57.34K	$54.69K	$57.35K
YoY Change	0.0%	-4.64%	0.0%
Cash From Operating Activities	-$5.852M	-$5.907M	-$8.009M
YoY Change	-50.14%	-26.25%	70.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$5.000K
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$5.000K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	15.98M	4.918M	32.53M
YoY Change	63.54%	-84.88%	122.64%
NET CHANGE
Cash From Operating Activities	-5.852M	-5.907M	-8.009M
Cash From Investing Activities	0.000	-5.000K
Cash From Financing Activities	15.98M	4.918M	32.53M
Net Change In Cash	10.12M	-994.2K	24.52M
YoY Change	-169.95%	-104.05%	147.56%
FREE CASH FLOW
Cash From Operating Activities	-$5.852M	-$5.907M	-$8.009M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001580149
CY2023Q4	bivi	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023Q4	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
CY2022Q4	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
	bivi	Realized Gain On Maturity Of Availablefor Sale RealizedGainOnMaturityOfAvailableforSale		usd
	bivi	Proceeds From Maturity Of U.S.Treasury Bills ProceedsFromMaturityOfU.s.TreasuryBills		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty		usd
	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement		usd
CY2022Q4	bivi	Cashless Exercise Of Options CashlessExerciseOfOptions		usd
CY2022Q4	bivi	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2023Q3	bivi	Issuance Of Common Stock From Vesting Of Restricted Stock Units IssuanceOfCommonStockFromVestingOfRestrictedStockUnits		usd
CY2023Q4	bivi	Notes Payable Noncurrent NotesPayableNoncurrent		usd
CY2023Q4	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts		usd
CY2023Q4	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables		usd
CY2023Q4	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums		usd
CY2023Q4	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39015
	dei	Entity Registrant Name EntityRegistrantName	BIOVIE INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2510769
	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 W Nye Lane
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 204
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carson City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89703
	dei	City Area Code CityAreaCode	775
	dei	Local Phone Number LocalPhoneNumber	888-3162
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	BIVI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39871098	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20226698	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19460883	usd
CY2023Q2	bivi	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills	14477726	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	334963	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	102526	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	20561661	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	34041135	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60418	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	522407	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	637095	usd
CY2023Q4	us-gaap	Goodwill Goodwill	345711	usd
CY2023Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2023Q4	us-gaap	Assets Assets	21490197	usd
CY2023Q2	us-gaap	Assets Assets	35104730	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3608096	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3476259	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48385	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48231	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2023Q4	bivi	Unearned Premium Anddiscount Current UnearnedPremiumAnddiscountCurrent	195325	usd
CY2023Q2	bivi	Unearned Premium Anddiscount Current UnearnedPremiumAnddiscountCurrent	894926	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10195325	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9105074	usd
CY2023Q4	bivi	Warrant Liabilities WarrantLiabilities	123158	usd
CY2023Q2	bivi	Warrant Liabilities WarrantLiabilities	894280	usd
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	6548	usd
CY2023Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	925762	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13981358	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14494669	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17604	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2023Q4	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	0	usd
CY2023Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	227270	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	5227270	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13998962	usd
CY2023Q2	us-gaap	Liabilities Liabilities	19764444	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39866714	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39843834	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36451829	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36428949	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3984	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3643	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	327824867	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	316385759	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	176591	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320337614	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301225705	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7491235	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21490197	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35104730	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6470262	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7032898	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15345922	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13802830	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2253802	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4404564	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4196619	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6411626	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	8781408	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	11494806	usd
	us-gaap	Operating Expenses OperatingExpenses	19657229	usd
	us-gaap	Operating Expenses OperatingExpenses	20329144	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-8781408	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-11494806	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19657229	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20329144	usd
CY2023Q4	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	982534	usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-3222010	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1690336	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-3788552	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	820600	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	1053455	usd
	us-gaap	Interest Expense InterestExpense	1825268	usd
	us-gaap	Interest Expense InterestExpense	2109871	usd
CY2023Q4	us-gaap	Interest Income Other InterestIncomeOther	218029	usd
CY2022Q4	us-gaap	Interest Income Other InterestIncomeOther	83269	usd
	us-gaap	Interest Income Other InterestIncomeOther	680252	usd
	us-gaap	Interest Income Other InterestIncomeOther	124854	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	379963	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4192196	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	545320	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5773569	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-8401445	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-15687002	usd
	us-gaap	Profit Loss ProfitLoss	-19111909	usd
	us-gaap	Profit Loss ProfitLoss	-26102713	usd
CY2023Q4	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-8401445	usd
CY2022Q4	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-15687002	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-19111909	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-26102713	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.89
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38170766	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31168826	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37444764	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29201445	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38170766	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31168826	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37444764	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29201445	shares
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8401445	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15687002	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19111909	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26102713	usd
	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement	-176591	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-176591	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8401445	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15687002	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19288500	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26102713	usd
	us-gaap	Profit Loss ProfitLoss	-19111909	usd
	us-gaap	Profit Loss ProfitLoss	-26102713	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	684007	usd
	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	1571990	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1427728	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2591427	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	68560	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	85110	usd
	bivi	Accretion Of Unearned Loan Discount AccretionOfUnearnedLoanDiscount	-645027	usd
	bivi	Accretion Of Unearned Loan Discount AccretionOfUnearnedLoanDiscount	-800722	usd
	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	149394	usd
	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	236540	usd
	bivi	Realized Gain On Maturity Of Availablefor Sale RealizedGainOnMaturityOfAvailableforSale	223865	usd
	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	20371	usd
	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	18216	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1690336	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3788552	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	232437	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	103403	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	131837	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	802610	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21579	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-18675	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-48385	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1014612	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18086899	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17229548	usd
	bivi	Proceeds From Maturity Of U.S.Treasury Bills ProceedsFromMaturityOfU.s.TreasuryBills	-14525000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14525000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9327714	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	38428343	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2240	usd
	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty	5905840	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4327714	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44336423	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	765815	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	27106875	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19460883	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20226698	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45748591	usd
	us-gaap	Interest Paid Net InterestPaidNet	962288	usd
	us-gaap	Interest Paid Net InterestPaidNet	987498	usd
	bivi	Reclassification Of Unrealized Gains On Availableforsale Investments Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentsUponSettlement	-176591	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	878640	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	17537	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5903682	usd
CY2022Q3	bivi	Proceeds From Issuance Of Common Stock Net Of Costs Related Party ProceedsFromIssuanceOfCommonStockNetOfCostsRelatedParty	5905840	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10415711	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5960923	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1554453	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1712787	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2240	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32524661	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-15687002	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26068062	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	808027	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	380834	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1905836	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-10710464	usd
CY2023Q3	bivi	Reclassification Of Unrealized Gains On Availableforsale Investment Upon Settlement ReclassificationOfUnrealizedGainsOnAvailableforsaleInvestmentUponSettlement	-176591	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7547928	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	619701	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	303173	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7421878	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8401445	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7491235	usd
CY2023Q4	bivi	Working Capital WorkingCapital	6600000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20200000	usd
CY2023Q4	bivi	Stockholder Equities StockholderEquities	7500000	usd
CY2023Q4	bivi	Accumulated Deficit AccumulatedDeficit	320300000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12631038	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11879110	shares
CY2023	bivi	Number Of Stock Purchased NumberOfStockPurchased	46000000	usd
	bivi	Realized Gain On Maturity Of Availablefor Sale RealizedGainOnMaturityOfAvailableforSale	223865	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1771363	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1656675	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	522407	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	637095	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114688	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	114689	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	229377	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	178341	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	522407	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	48000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0850	pure
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1400000	usd
	bivi	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	2200000	usd
CY2023	bivi	Unearned Discount UnearnedDiscount	3600000	usd
	bivi	Direct Financing Cost DirectFinancingCost	390000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	850000	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	682000	usd
CY2023Q4	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	429000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	31000	usd
CY2023Q4	bivi	Unearned Discount UnearnedDiscount	289000	usd
CY2023Q4	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	67000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1500000	usd
	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	955000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	69000	usd
	bivi	Unearned Discount UnearnedDiscount	645000	usd
	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	149000	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1100000	usd
CY2022Q4	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	518000	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	usd
CY2022Q4	bivi	Unearned Discount UnearnedDiscount	400000	usd
CY2022Q4	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	93000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2100000	usd
	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	987000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	85000	usd
	bivi	Unearned Discount UnearnedDiscount	801000	usd
	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	237000	usd
CY2023Q4	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	10000000	usd
CY2023Q2	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	10000000	usd
CY2023Q4	bivi	Debt Financing Costs DebtFinancingCosts	-52011	usd
CY2023Q2	bivi	Debt Financing Costs DebtFinancingCosts	-108751	usd
CY2023Q4	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	489330	usd
CY2023Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	1023145	usd
CY2023Q4	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	736666	usd
CY2023Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	236970	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10195325	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9105074	usd
CY2023Q2	bivi	Notes Payable Noncurrent NotesPayableNoncurrent	5000000	usd
CY2023Q2	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts	-11820	usd
CY2023Q2	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	-111212	usd
CY2023Q2	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums	350302	usd
CY2023Q2	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount	5227270	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	129706	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1820042	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20226698	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	33938609	usd
CY2022Q4	bivi	Total Compensation Cost TotalCompensationCost	1744192	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	596457	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.24
	bivi	Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedNumberOfShares	182696	shares
	bivi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriodWeightedAverageGrantDateFairValue	3.01
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	81422	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	10303	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	6.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	687428	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.71
CY2023Q4	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	303173	usd
CY2022Q4	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	1554453	usd
	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	684007	usd
	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	1571990	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	13000	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	13000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	26000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	26000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60418	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48231	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17604	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	65835	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	87414	usd
	bivi	Schedule Of Future Estimated Minimum Lease Payments Under Non Cancelable Operating Leases ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases	<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases_zvqBYZ3KIBJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z75tEXnwuGZ2" style="display: none">Schedule of future estimated minimum lease payments under non-cancelable operating leases</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_497_20231231" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_zaX2Ipg3S2Nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 85%">Year ending June 30, 2024 (Remaining 6 months)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26,356</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_zUeXo4bx2the" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">44,636</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_zaNqj6FQSt7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,992</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment_iNI_pp0p0_zbAfSRsLNPYg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less amount representing interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,157</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zJ1ovx5zmFK7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,835</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zzJulo8Kyktf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion of operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(48,231</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zflsBIqvomi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Operating lease liabilities, net of current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,604</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	26356	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	44636	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	70992	usd
CY2023Q4	bivi	Capital Leases Future Minimum Payments Interest Included In Payment CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment	-5157	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	65835	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48231	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17604	usd
CY2023Q4	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	25800	usd
CY2022Q4	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	25050	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2023Q4	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	20500	usd
CY2022Q4	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	19000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	51400	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	64200	usd

Files In Submission

Name	View Source	Status
0001520138-24-000069-index-headers.html	Edgar Link	pending
0001520138-24-000069-index.html	Edgar Link	pending
0001520138-24-000069.txt	Edgar Link	pending
0001520138-24-000069-xbrl.zip	Edgar Link	pending
bivi-20231231.xsd	Edgar Link	pending
bivi-20231231_10q.htm	Edgar Link	pending
bivi-20231231_10qex31z1.htm	Edgar Link	pending
bivi-20231231_10qex31z2.htm	Edgar Link	pending
bivi-20231231_10qex32z1.htm	Edgar Link	pending
bivi-20231231_10qex32z2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
bivi-20231231_cal.xml	Edgar Link	unprocessable
bivi-20231231_def.xml	Edgar Link	unprocessable
bivi-20231231_lab.xml	Edgar Link	unprocessable
bivi-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bivi-20231231_10q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIVI
BIOVIE INC. Stock $bivi

2024 Q1 Form 10-Q Financial Statement

#000152013824000069 Filed on February 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI BIOVIE INC. Stock $bivi

2024 Q1 Form 10-Q Financial Statement

#000152013824000069 Filed on February 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI
BIOVIE INC. Stock $bivi